Palmetto Infusion Services, LLC, is pleased to announce the addition of Jeremy Bunch to its Executive Leadership team.
Bunch has more than 20 years of healthcare-industry experience with a strong foundation in biotech and pharmaceutical leadership. A graduate of the University of Tulsa with a Bachelor of Arts in communication and a minor in marketing, he has been a key member of several pharmaceutical companies, including as regional business director of the Mid-Atlantic with Adamas Pharmaceuticals and regional business director of the Carolinas with Sanofi Genzyme. During his tenure with these companies, Bunch launched an orphan drug for the treatment of Parkinson’s Disease, Gocovri, and two transformative MS therapies, Aubagio and Lemtrada.
“Jeremy brings over two decades of high-level experience working in the healthcare industry, and we are extremely excited to have someone of his caliber joining our team,” said David Goodall, CEO of Palmetto.“His incredible range of industry knowledge and leadership abilities will be instrumental in guiding us as we continue to grow and expand our company into new markets.”
“Palmetto Infusion has built a reputation by fostering customer relationships and for its commitment to providing cutting-edge treatments for patients with chronic conditions,” said Bunch. “I am thrilled to join a company whose values side with my core tenets.”
About Palmetto Infusion:
Founded in 1999, Palmetto provides comprehensive ambulatory and home-based infusion services to both acute and chronically ill patients. Our compassionate team of experts delivers a cost-effective and seamless care experience that surpasses all others.With 18 locations in South and North Carolina and over 250 employees, we are committed to providing patients living with chronic illness a safe, convenient, and more affordable place to receive treatments that improve their quality life.